Abstract
The subjects of the study are a 48-year old male and a 50-year female patient with the idiopathic form of pyoderma gangrenosum. Both patients were treated with Cyclosporin A (Sandimmun) as monotherapy. Complete resolution was achieved after three months’ treatment. No serious side-effects were observed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brunsting LA, Goeckerman WH, O’Leary PA. Pyoderma (ecthyma) gangrenosum: Clinical and experimental observations in five cases occuring in adults. Arch Dermatol 22:655–680 (1930)
Jones RR: Cutaneous manifestations of paraproteinemia. Br J Dermatol. 104:209–220 (1981)
Borel JF. In: Kahan B, ed. Cyclosporine:Nature of the Agent and its Immunologic Actions. New York, NY:Guine and Stratton 722–730 (1988)
Furue M, Gaspari A, Katz S. The effect of cyclosporin A on epidermal cells II: cyclosporin A inhibits proliferation of normal and transformed keratinocytes. J Invest Dermatol 90:796–800 (1988).
Elgart G, Larson K, Stover P, Davis B. Effective treatment of pyoderma gangrenosum with cyclosporin: a report of five cases. J Invest Dermatol. 92:424 (1989)
Magid ML, Gold MH. Treatment of recalcitrant pyoderma gangrenosum with cyclosporine. J Am Acad Dermatol. 20:293–294 (1989).
Curley RK, Mcfarlane AW, Vickers CFH. Pyoderma Gangrenosum treated with Cyclosporine. Br J Dermatol. 113:601–604(1985).
Ho VC, Dutz J, Gulliver W, Lauzon G. Canadian experience of cyclosporin A (Sandimmun and Sandimmun Neoral) in the treatment of refractory pyoderma gangrenosum. International Congress on Immunointervention. The Role of Neoral in Immune-Based Diseases. Rome, Italy, June 1996 (Abstracts)
Mork NJ, Mork G, Koss-Harnes D. Severe pyoderma gangrenosum successfully treated with cyclosporin. International Congress on Immunointervention. The Role of Neoral in Immune-Based Diseases. Rome, Italy, June 1996 (Abstracts)
Wang DZ, McCafrey PG, Rao A. The Cyclosporin-sensitive transcription factor NFATp is expressed in several classes of cells in the immune system. Ann New York Acad Sci 766:182–194 (1995)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
V’lčkova-Laskoska, M.T., Laskoski, D.S., Caca-Biljanovska, N.G., Darkoska, J.S. (1999). Pyoderma Gangrenosum Successfully Treated with Cyclosporin A. In: Mallia, C., Uitto, J. (eds) Rheumaderm. Advances in Experimental Medicine and Biology, vol 455. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4857-7_81
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4857-7_81
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7203-5
Online ISBN: 978-1-4615-4857-7
eBook Packages: Springer Book Archive